Free Trial

Welltower (WELL) Stock Forecast & Price Target

$130.74
+0.39 (+0.30%)
(As of 10/17/2024 ET)

Welltower - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
9

Based on 13 Wall Street analysts who have issued ratings for Welltower in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 4 have given a hold rating, 7 have given a buy rating, and 2 have given a strong buy rating for WELL.

Consensus Price Target

$115.38
-11.75% Downside
According to the 13 analysts' twelve-month price targets for Welltower, the average price target is $115.38. The highest price target for WELL is $137.00, while the lowest price target for WELL is $99.00. The average price target represents a forecasted downside of -11.75% from the current price of $130.74.
Get the Latest News and Ratings for WELL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Welltower and its competitors.

Sign Up

WELL Analyst Ratings Over Time

TypeCurrent Forecast
10/19/23 to 10/18/24
1 Month Ago
9/19/23 to 9/18/24
3 Months Ago
7/21/23 to 7/20/24
1 Year Ago
10/19/22 to 10/19/23
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
8 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
Hold
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$115.38$112.38$101.32$87.77
Forecasted Upside-11.75% Downside-11.97% Downside-5.67% Downside4.59% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

WELL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

WELL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Welltower Stock vs. The Competition

TypeWelltowerReal Estate CompaniesS&P 500
Consensus Rating Score
2.85
2.59
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside-11.75% Downside17.63% Upside6.31% Upside
News Sentiment Rating
Positive News

See Recent WELL News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/1/2024Wells Fargo & Company
3 of 5 stars
J. Feldman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$134.00 ➝ $135.00+5.76%
9/23/2024Scotiabank
5 of 5 stars
 Boost TargetSector Outperform ➝ Sector Outperform$121.00 ➝ $133.00+5.34%
9/16/2024Evercore ISI
2 of 5 stars
 Boost TargetIn-Line ➝ In-Line$106.00 ➝ $114.00-11.88%
8/21/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$115.00 ➝ $137.00+17.67%
8/9/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Rosivach
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/9/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$101.00 ➝ $114.00-2.70%
8/5/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$100.00 ➝ $120.00+6.76%
7/11/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$103.00 ➝ $107.50+3.54%
7/2/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$95.00 ➝ $115.00+10.58%
5/8/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$98.00 ➝ $105.00+7.74%
3/18/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$104.00+13.85%
12/18/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$92.00 ➝ $99.00+9.04%
11/9/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeOutperform ➝ Strong-Buy$95.00 ➝ $101.00+16.94%
9/14/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$80.00 ➝ $84.00+1.72%
8/2/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$82.00 ➝ $92.00+8.75%
4/5/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$70.00 ➝ $81.00+14.80%
4/3/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$72.00 ➝ $80.00+11.59%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 02:02 AM ET.


Should I Buy Welltower Stock? WELL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 11, 2024. Please send any questions or comments about these Welltower pros and cons to contact@marketbeat.com.

Welltower
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Welltower Inc.:

  • Welltower Inc. has shown consistent growth in revenue, with a 9.6% increase in the most recent quarter, indicating a healthy financial performance.
  • With a market capitalization of $76.41 billion, Welltower Inc. is a significant player in the real estate investment trust sector, providing stability and potential for long-term growth.
  • Welltower Inc. reported a return on equity of 2.21%, showcasing the company's ability to generate profit from shareholders' equity.
  • Investors may find Welltower Inc.'s current stock price of $127.79 attractive, considering the company's strong market position and growth potential.
  • Welltower Inc. has a diverse portfolio in the real estate sector, offering investors exposure to various segments and reducing risk associated with concentration in a single area.

Welltower
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Welltower Inc. for these reasons:

  • Welltower Inc.'s price-to-earnings ratio of 157.11 may indicate that the stock is currently overvalued, potentially limiting short-term gains for investors.
  • The company's PEG ratio of 2.97 suggests that the stock may be overpriced relative to its expected earnings growth, raising concerns about valuation.
  • Welltower Inc. has a beta of 1.21, indicating higher volatility compared to the market average, which could lead to increased risk for investors.
  • The debt-to-equity ratio of 0.47 for Welltower Inc. may raise concerns about the company's leverage and financial stability in challenging economic conditions.
  • While Welltower Inc. has shown growth, the net margin of 8.36% may be considered low by some investors, impacting the company's profitability and potential returns.

WELL Forecast - Frequently Asked Questions

According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Welltower is $115.38, with a high forecast of $137.00 and a low forecast of $99.00.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Welltower in the last twelve months. There are currently 4 hold ratings, 7 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" WELL shares.

According to analysts, Welltower's stock has a predicted downside of -11.75% based on their 12-month stock forecasts.

Over the previous 90 days, Welltower's stock had 1 upgrade by analysts.

Welltower has been rated by research analysts at Deutsche Bank Aktiengesellschaft, Evercore ISI, Royal Bank of Canada, Scotiabank, Wedbush, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Welltower more than other "real estate" companies. The consensus rating score for Welltower is 2.85 while the average consensus rating score for "real estate" companies is 2.57. Learn more on how WELL compares to other companies.


This page (NYSE:WELL) was last updated on 10/18/2024 by MarketBeat.com Staff
From Our Partners